methamphetamine and muromonab-cd3

methamphetamine has been researched along with muromonab-cd3 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braden, BB; Butler, TR; Prendergast, MA; Self, RL; Smith, KJ1

Other Studies

1 other study(ies) available for methamphetamine and muromonab-cd3

ArticleYear
Potentiation of N-methyl-D-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors.
    Brain research, 2008, Jan-02, Volume: 1187

    Topics: Animals; Animals, Newborn; Cell Death; Cell Survival; Central Nervous System Stimulants; Drug Interactions; Drug Synergism; Excitatory Amino Acid Antagonists; Female; Hippocampus; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Male; Methamphetamine; Nerve Degeneration; Organ Culture Techniques; Oxazoles; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome

2008